Skip to main content
Jennie Crews, MD, Oncology, Palo Alto, CA

Jennie R Crews MD


Associate Chief Medical Officer, Ambulatory Care, Stanford Health Care Chief Medical Officer, Stanford Medicine Partners

Join to View Full Profile
  • 300 Pasteur DrPalo Alto, CA 94304

  • Phone+1 650-723-4000

Dr. Crews is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • USC Marshall School of Business
    USC Marshall School of BusinessMaster Medical Management (MMM), Business, 2015 - 2016
  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 1993 - 1995
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1990 - 1993
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1990

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2022 - 2026
  • WA State Medical License
    WA State Medical License 2012 - 2026
  • NC State Medical License
    NC State Medical License 1992 - 2025
  • AK State Medical License
    AK State Medical License 2013 - 2021
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Fellow (FACP) American College of Physicians, 2002

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • ELP1 Loss Disrupts Protein Homeostasis to Promote SHH Medulloblastoma
    ELP1 Loss Disrupts Protein Homeostasis to Promote SHH MedulloblastomaJune 1st, 2020
  • Cysteine Is Required for Preventing Ferroptosis in Pancreatic Cancer
    Cysteine Is Required for Preventing Ferroptosis in Pancreatic CancerJune 1st, 2020
  • Specific Helical Domain Contacts Mediate PARP1 Inhibitor Activity
    Specific Helical Domain Contacts Mediate PARP1 Inhibitor ActivityJune 1st, 2020
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: